Comparison of single-agent chemotherapy and targeted therapy to first-line treatment in patients aged 80 years and older with advanced non-small-cell lung cancer-Reference-Cited by-同舟云学术

Comparison of single-agent chemotherapy and targeted therapy to first-line treatment in patients aged 80 years and older with advanced non-small-cell lung cancer

Published:2015-04 Issue: Volume: Page:893
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Wang Zhehai,Zhang Qianqian,Guo jun,Liu Liyan,Han Xiao,Li Minmin,Fang Shu,Bi Xiang,Tang Ning,Liu Yang

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ПОШУК НОВИХ ІНГІБІТОРІВ ТИРОЗИНКІНАЗИ СЕРЕД 2-(3-R-1H-1,2,4-ТРИАЗОЛ-5-ІЛ)АНІЛІНІВ ЯК ПОТЕНЦІЙНИХ ПРОТИПУХЛИННИХ АГЕНТІВ З ВИКОРИСТАННЯМ МОЛЕКУЛЯРНОГО ДОКІНГУ;Journal of Chemistry and Technologies;2023-07-25

2. Development and Optimization of Osimertinib-loaded Biodegradable Polymeric Nanoparticles Enhance In-vitro Cytotoxicity in Mutant EGFR NSCLC Cell Models and In-vivo Tumor Reduction in H1975 Xenograft Mice Models;AAPS PharmSciTech;2022-06-08

3. Oncogenic circRNA C190 Promotes Non–Small Cell Lung Cancer via Modulation of the EGFR/ERK Pathway;Cancer Research;2021-11-09

4. Design of more potent quinazoline derivatives as EGFRWT inhibitors for the treatment of NSCLC: a computational approach;Future Journal of Pharmaceutical Sciences;2021-07-12

5. Computer-aided design of some quinazoline analogues as epidermal growth factor receptor inhibitors;Egyptian Journal of Medical Human Genetics;2021-06-28